• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Yuling,GUO Dainian,CHEN Chen,FANG Ling.Determination of total platinum in tumor patient serum after medication by GFAAS with resolution method[J].Journal Of Pharmaceutical Research,2020,39(4):193-197[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3022times   Download 3448次 QR Code for this article
Scan with your phone!
消解-GFAAS法检测肿瘤患者用药后血清中总铂的方法研究
张浴玲1,郭岱年2,陈晨2,方翎2
Font:Larger+|Default|Smaller-
(1.汕头大学医学院环境医学与发育毒理学实验室,广东 汕头 515041;2.汕头大学医学院附属肿瘤医院静脉用药调配中心,广东 汕头 515041)
摘要:
目的 针对目前对人体总铂的浓度检测方法不一,缺乏既定标准且检测成本较高的现象,探索国内较常用的仪器-原子吸收分光光度仪检测肿瘤患者用药后血清中总铂浓度的方法。方法 使用石墨炉原子吸收分光光度仪(GFAAS-650)检测肿瘤患者用药后的血清总铂浓度,以吸光度大小、峰型作为判断标准,判定适合的温度程序,通过回收率验证所得温度程序的适用性,并确定前处理过程是否需要使用基体改进剂。结果 获得以1 150 ℃为灰化温度、2 700 ℃为原子化温度的石墨炉升温程序为最佳程序,检测结果回收率为94.77%,前处理过程不需使用基体改进剂,方法检出限为31.16 μg·L-1。结论 本方法前处理过程简便,准确度及灵敏度高,经济成本低,适合大部分医疗或科研单位进行患者总铂含量监测。
关键词:  铂  血清  原子吸收  检测
DOI:10.13506/j.cnki.jpr.2020.04.002
基金项目:汕头市科技计划项目(No.2016-6);广东省科技计划项目(No.2014A020212505)
Determination of total platinum in tumor patient serum after medication by GFAAS with resolution method
ZHANG Yuling1,GUO Dainian2,CHEN Chen2,FANG Ling2
(1.Laboratory of Environmental Medicine and Developmental Toxicology, Shantou University Medical College,Shantou 515041,China;2.Pharmacy Intravenous Admixture Service,Cancer Hospital of Shantou University Medical College,Shantou 515041,China)
Abstract:
Objective To obtain a method of determination on serum platinum from tumor patients after medication by atomic absorption spectrophotometer, directing at the inconsistent methods and high cost on the detection of total platinum concentration in human body. Methods To determinate platinum concentration of cancer patient serum by GFAAS-650 with the methods of manufacturers recommending and adjusting. The valuations of temperature programs contained absorption, peak and recovery. Absorption and peak were also to use to estimate whether to add matrix modifier or nitric acid only.Results The program with an ashing temperature of 1 150℃ and atomization temperature of 2 700 ℃ was best one for the detection of serum platinum, while its recovery was 94.77% without any matrix modifier and the limit of detection was 31.16 μg·L-1. Digestion without matrix modifier for the sample pretreatment was the proper method.Conclusion We got a convenient, accurate and sensitive method on the determination of total platinum in patients for most medical and scientific institutes with lower cost.
Key words:  Platinum  Serum  Atomic absorption  Determination
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.